Amazon founder Jeff Bezos has reportedly invested in a startup which is trying to find a way to reverse the human ageing process and grant immortality to individuals, according to MIT Tech Review.
The startup – Altos Labs – was founded earlier in 2021, and is offering scientists salaries of over €840,000 per year to research cell aging and how to biologically reverse the process.
According to the MIT report, the company has raised at least €227 million, and plans to set up labs across the world, from San Diego, to Cambridge, and even Japan.
Additionally, Spanish biologist Juan Carlos Izpisúa Belmonte is said to be joining the company. Controversially, Belmonte is known for mixing human and monkey embryos as part of his prior research.
Some of the experts who had been headhunted said that Altos Labs planned to pay them 10 times their current salary, and that they would be happy to come on board.
“The philosophy of Altos Labs is to do curiosity-driven research. This is what I know how to do and love to do,” said Manuel Serrano of the Institute for Research in Biomedicine in Barcelona.
“In this case, through a private company, we have the freedom to be bold and explore. In this way it will rejuvenate me.”
He added that the goal was not to make money, but to “aim to understand rejuvenation.”
“I would say the idea of having revenue in the future is there, but it’s not the immediate goal.”
Altos Labs is not the only company looking into this type of technology, however. Calico Labs, which was created in 2013, 8 years ago, by Google co-founder Larry Page, also hired top scientists with large pay cheques in an effort to crack the secret to human immortality.
Now Bezos, at age 57, will attempt something similar.
Earlier this year, Israeli scientists found a way to extend the lifespan of mice by 23% by boosting a particular protein, and say this method may work on humans.
“The change in life expectancy is significant, when you consider that an equivalent jump in human life expectancy would have us living on average until almost 120,” said Prof. Haim Cohen of Bar-Ilan University.
In addition to extending the mice’s lifespan, this method also made them more youthful at a later age and less susceptible to cancer.
They've figured how mice can live longer.
Now we just have to figure out the drugs to boost the SIRT6 protein in us bipeds.https://t.co/kVj1gw1Yw3
— Thack (@DaveThackeray) June 3, 2021